Phase I-II, Not-Randomized, Multicenter Clinical Trial to Evaluate Safety and Efficacy of Sorafenib (BAY-43-9006) in Combination With Ifosfamide in Soft Tissue Sarcoma.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ifosfamide; Sorafenib
- Indications Sarcoma
- Focus Adverse reactions; Therapeutic Use
- 16 Jan 2012 Planned number of patients changed from 24 to 59.
- 16 Jan 2012 Planned End Date changed from 1 Apr 2010 to 27 Feb 2010.
- 19 Oct 2007 New trial record.